Cargando…
n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and α-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease
BACKGROUND: Parkinson's disease (PD) is the second most common degenerative disorder of the central nervous system that impairs motor skills and cognitive function. To date, the disease has no effective therapies. The identification of new drugs that provide benefit in arresting the decline see...
Autores principales: | Fu, Ru-Huei, Harn, Horng-Jyh, Liu, Shih-Ping, Chen, Chang-Shi, Chang, Wen-Lin, Chen, Yue-Mi, Huang, Jing-En, Li, Rong-Jhu, Tsai, Sung-Yu, Hung, Huey-Shan, Shyu, Woei-Cherng, Lin, Shinn-Zong, Wang, Yu-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885701/ https://www.ncbi.nlm.nih.gov/pubmed/24416384 http://dx.doi.org/10.1371/journal.pone.0085305 |
Ejemplares similares
-
n-Butylidenephthalide (BP) Maintains Stem Cell Pluripotency by Activating Jak2/Stat3 Pathway and Increases the Efficiency of iPS Cells Generation
por: Liu, Shih-Ping, et al.
Publicado: (2012) -
Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM
por: Liu, Ching-Ann, et al.
Publicado: (2022) -
Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson’s Disease
por: Tsai, Chia-Wen, et al.
Publicado: (2018) -
The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration
por: Chuang, Hong-Meng, et al.
Publicado: (2016) -
n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway
por: Lee, Jui-Hao, et al.
Publicado: (2021)